|
Dr. Pollevick is the Director of Operations
of the Clinical Laboratories for the
Connecticut and Nebraska facilities. Dr.
Pollevick has over 20 years of experience in
both genetics research and diagnostics and
in the development and application of
molecular biological techniques. His career
has been devoted to translational medicine,
including the discovery of genes responsible
for sudden cardiac death. His contributions
include over 40 original articles in
scientific journals like Cell, Circulation,
and Nature Biotechnology, two patents, and
book chapters. Dr. Pollevick previously
served as Laboratory Director for PGxHealth
in New Haven, CT as well as the Molecular
Genetics Laboratory at the Masonic Medical
Research Laboratory in Utica N.Y. Dr.
Pollevick holds a Certificate of
Qualification from the NYS Department of
Health and trained in Ethics and Genetics
Research from Duke University School of
Medicine. The US Congress recognized his
contributions with an award for Medical
Cures and Treatments for Cardiac Diseases.
Dr. Pollevick received a B.A. in Biological
Sciences and a Ph.D. in Chemical Sciences
from the University of Buenos Aires,
Argentina. His doctoral work was also done
at the Department of Medical Genetics of the
Biomedical Center at Uppsala University in
Sweden.
|
|